| Gut microbiota promote angiotensin II–induced arterial hypertension and vascular dysfunction SH Karbach, T Schönfelder, I Brandão, E Wilms, N Hörmann, S Jäckel, ... Journal of the American Heart Association 5 (9), e003698, 2016 | 335 | 2016 |
| Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: Insights from an eplerenone post … V Regnault, J Lagrange, A Pizard, ME Safar, R Fay, B Pitt, P Challande, ... Hypertension 63 (1), 105-111, 2014 | 110 | 2014 |
| Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension S Kossmann, J Lagrange, S Jäckel, K Jurk, M Ehlken, T Schönfelder, ... Science Translational Medicine 9 (375), eaah4923, 2017 | 96 | 2017 |
| Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans P Wenzel, H Rossmann, C Müller, S Kossmann, M Oelze, A Schulz, ... European heart journal 36 (48), 3437-3446, 2015 | 91 | 2015 |
| Endothelial α1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunction S Kröller-Schön, T Jansen, TLP Tran, M Kvandová, S Kalinovic, M Oelze, ... Basic Research in Cardiology 114, 1-12, 2019 | 38 | 2019 |
| T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of ⋅NO/cGMP Signaling R Schüler, P Efentakis, J Wild, J Lagrange, V Garlapati, M Molitor, ... Oxidative medicine and cellular longevity 2019, 2019 | 37 | 2019 |
| Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1 M Molitor, WS Rudi, V Garlapati, S Finger, R Schüler, S Kossmann, ... Cardiovascular research 117 (1), 162-177, 2021 | 33 | 2021 |
| Alpha‐2‐macroglobulin in hemostasis and thrombosis: An underestimated old double‐edged sword J Lagrange, T Lecompte, T Knopp, P Lacolley, V Regnault Journal of Thrombosis and Haemostasis 20 (4), 806-815, 2022 | 31 | 2022 |
| The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells J Lagrange, ME Worou, JB Michel, A Raoul, M Didelot, V Muczynski, ... Cardiovascular Research 118 (2), 622-637, 2022 | 27 | 2022 |
| Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice J Lagrange, Z Li, C Fassot, M Bourhim, H Louis, AND Cat, A Parlakian, ... The FASEB Journal 28 (5), 2062-2072, 2014 | 26 | 2014 |
| Shedding light on hemostasis in patients with inflammatory bowel diseases J Lagrange, P Lacolley, D Wahl, L Peyrin-Biroulet, V Regnault Clinical Gastroenterology and Hepatology 19 (6), 1088-1097. e6, 2021 | 24 | 2021 |
| α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction T Jansen, S Kröller-Schön, T Schönfelder, M Foretz, B Viollet, A Daiber, ... Cardiovascular research 114 (14), 1883-1893, 2018 | 23 | 2018 |
| The resolvin D2–GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice M Bardin, SC Pawelzik, J Lagrange, A Mahdi, H Arnardottir, V Regnault, ... Biochemical Pharmacology 201, 115075, 2022 | 22 | 2022 |
| Hypertension, hypercoagulability and the metabolic syndrome: A cluster of risk factors for cardiovascular disease X Mao, K Ait-Aissa, J Lagrange, G Youcef, H Louis Bio-medical materials and engineering 22 (1-3), 35-48, 2012 | 22 | 2012 |
| Vascular smooth muscle cells are responsible for a prothrombotic phenotype of spontaneously hypertensive rat arteries K Ait Aissa, J Lagrange, A Mohamadi, H Louis, B Houppert, P Challande, ... Arteriosclerosis, thrombosis, and vascular biology 35 (4), 930-937, 2015 | 17 | 2015 |
| Conductance artery wall layers and their respective roles in the clearance functions JB Michel, J Lagrange, V Regnault, P Lacolley Arteriosclerosis, Thrombosis, and Vascular Biology 42 (9), e253-e272, 2022 | 15 | 2022 |
| A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance T Foret, V Dufrost, L Salomon du Mont, P Costa, C Lakomy, J Lagrange, ... Rheumatology 61 (7), 2993-2998, 2022 | 15 | 2022 |
| Targeting myeloid cell coagulation signaling blocks MAP kinase/TGF-β1–driven fibrotic remodeling in ischemic heart failure V Garlapati, M Molitor, T Michna, GS Harms, S Finger, R Jung, J Lagrange, ... The Journal of Clinical Investigation 133 (4), 2023 | 14 | 2023 |
| Rivaroxaban effects illustrate the underestimated importance of activated platelets in thrombin generation assessed by calibrated automated thrombography S Makhoul, M Panova-Noeva, V Regnault, W Ruf, P Wenzel, J Lagrange Journal of Clinical Medicine 8 (11), 1990, 2019 | 14 | 2019 |
| Platelet aggregation impacts thrombin generation assessed by calibrated automated thrombography M Didelot, C Docq, D Wahl, P Lacolley, V Regnault, J Lagrange Platelets 29 (2), 156-161, 2018 | 13 | 2018 |
